aTYR PHARMA INC - COMMON STOCK (ATYR)

Historical Holders from Q2 2019 to Q3 2025

Symbol
ATYR on Nasdaq
CUSIP
002120202
Type / Class
Equity / COMMON STOCK
Shares outstanding
98M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
66.3M
Holdings value
$336M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
108
Number of buys
75
Number of sells
-53
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of aTYR PHARMA INC - COMMON STOCK (ATYR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FEDERATED HERMES, INC. 10.76% -39.5% $55.5M -$21.7M 10.5M -28.1% Federated Hermes, Inc. Sep 30, 2025
BlackRock, Inc. 6.5% $18.7M 5.76M BlackRock, Inc. Jun 30, 2025
VANGUARD GROUP INC 5.23% $15.1M 4.66M The Vanguard Group Jun 30, 2025
Point72 Asset Management, L.P. 3.2% $8.11M 2.85M Point72 Asset Management, L.P. Mar 31, 2025

Institutional Holders of aTYR PHARMA INC - COMMON STOCK (ATYR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 274K $198K +$121K $0.72 4
2025 Q2 66.3M $336M +$26.8M $5.07 108
2025 Q1 61.8M $187M +$18.9M $3.02 86
2024 Q4 54.9M $199M +$28.6M $3.62 77
2024 Q3 47.9M $84.2M -$407K $1.76 54
2024 Q2 48.1M $75.1M +$8.93M $1.56 45
2024 Q1 41.8M $81.5M +$1.48M $1.95 56
2023 Q4 41.2M $58.1M +$3.55M $1.41 45
2023 Q3 37.1M $58.7M +$2.05M $1.58 41
2023 Q2 35.7M $77M +$2.32M $2.16 41
2023 Q1 34.7M $72.8M +$35.3M $2.10 37
2022 Q4 18.4M $40.2M -$2.08M $2.19 35
2022 Q3 19M $57M +$782K $3.00 31
2022 Q2 18.8M $53.1M -$3.1M $2.83 35
2022 Q1 19.6M $105M -$6.16M $5.35 38
2021 Q4 20.5M $153M +$3.92M $7.47 45
2021 Q3 18.8M $171M +$109M $9.08 39
2021 Q2 6.79M $33.1M +$4.92M $4.88 23
2021 Q1 5.78M $25.7M +$195K $4.45 19
2020 Q4 5.76M $22.4M -$373K $3.88 18
2020 Q3 5.63M $18.2M +$464K $3.23 19
2020 Q2 5.47M $24.3M +$1.6M $4.44 21
2020 Q1 5.11M $14.3M +$9.33M $2.80 21
2019 Q4 1.79M $7.48M +$297K $4.17 13
2019 Q3 1.72M $6.01M +$4.15M $3.50 13
2019 Q2 530K $193K +$193K $0.36 5